Columbus Macro LLC Has $8.03 Million Holdings in Cardinal Health, Inc. $CAH

Columbus Macro LLC grew its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 6.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,061 shares of the company’s stock after buying an additional 2,532 shares during the quarter. Columbus Macro LLC’s holdings in Cardinal Health were worth $8,027,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of CAH. Strategy Asset Managers LLC bought a new stake in shares of Cardinal Health during the third quarter worth $775,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Cardinal Health by 15.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after buying an additional 5,030 shares during the last quarter. Versor Investments LP acquired a new position in Cardinal Health during the 3rd quarter worth about $2,090,000. Atle Fund Management AB lifted its position in Cardinal Health by 13.1% during the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after buying an additional 3,500 shares in the last quarter. Finally, Candriam S.C.A. grew its holdings in Cardinal Health by 10.8% during the 3rd quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock worth $30,790,000 after acquiring an additional 19,155 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.0%

NYSE CAH opened at $206.61 on Monday. Cardinal Health, Inc. has a 12 month low of $120.72 and a 12 month high of $233.60. The stock has a 50-day simple moving average of $217.41 and a 200 day simple moving average of $196.77. The company has a market capitalization of $48.62 billion, a PE ratio of 29.73, a P/E/G ratio of 1.33 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to analysts’ expectations of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.93 earnings per share. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is currently 29.35%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. TD Cowen boosted their target price on shares of Cardinal Health from $233.00 to $251.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Leerink Partners reissued an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. Barclays boosted their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. UBS Group set a $260.00 price objective on Cardinal Health and gave the stock a “buy” rating in a report on Friday, February 6th. Finally, Jefferies Financial Group increased their price objective on Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $245.67.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.